The Interactions between Bacillus anthracis and Macrophages

Bacillus anthracis and Anthrax

Volumn , Issue , 2010, Pages 179-208

  Welkos, Susan L ^a   Bozue, Joel A ^a   Cote, Christopher K ^a  

^a United States Army Medical Research Institute of Infectious Diseases   (United States)

Author keywords

Bacillus anthracis and macrophage interactions; Macrophage role in innate host defenses; Phagocytosis of B. anthracis Ames strain spores by macrophages, determined by immunofl uorescence microscopy

Indexed keywords

EID: 84888656864     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470891193.ch10     Document Type: Chapter

References (197)

1. Abrami, L., Reig, N., and van der Goot, F. G. 2005. Anthrax toxin: the long and winding road that leads to the kill. Trends in Microbiology, 13, 72 - 78.
2. Arbibe, L., Vial, D., Rosinski-Chupin, I. et al. 1997. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis. Journal of Immunology, 159, 391 - 400.
3. Arbibe, L., Koumanov, K., Vial, D. et al. 1998. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. Journal of Clinical Investigations, 102, 1152 - 1160.
4. Bail, O. 1914. Changes to bacteria inside the animal body. IX. Regarding the correlation between capsule formation, spore formation and infectiousness of the anthrax bacillus. Zentralblatt Bakteriologie, 75, 159 - 173.
5. Baldari, C. T., Tonello, F., Paccani, S. R., and Montecucco, C. 2006. Anthrax toxins: A paradigm of bacterial immune suppression. Trends in Immunology, 27, 434 - 440.
6. Banks, D. J., Barnajian, M., Maldonado-Arocho, F. J. et al. 2005. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cellular Microbiology, 7, 1173 - 1185.
7. Banks, D. J., Ward, S. C., and Bradley, K. A. 2006. New insights into the functions of anthrax toxin. Expert Reviews in Molecular Medicine, 8, 1 - 18.
8. Barnes, J. M. 1947. The Development of Anthrax Following the Administration of Spores by Inhalation. British Journal of Experimental Pathology, 28, 385 - 393.
9. Barua, S., McKevitt, M., DeGiusti, K. et al. 2009. The mechanism of Bacillus anthracis intracellular germination requires multiple and highly diverse genetic loci. Infection and Immunity, 77, 23 - 31.
10. Basu, S., Kang, T. J., Langermann, S. et al. 2007. A monoclonal antibody that neutralizes lethal toxin mediates the killing of B. anthracis by murine macrophages. In Bacillus-ACT, ed. A.-B. Kolst ø. Oslo, Norway: University of Oslo, p. 17.
11. Bergman, N. H., Passalacqua, K. D., Gaspard, R. et al. 2005. Murine macrophage transcriptional responses to Bacillus anthracis infection and intoxication. Infection and Immunity, 73, 1069 - 1080.
12. Bergman, N. H., Anderson, E. C., Swenson, E. E. et al. 2007. Transcriptional profi ling of Bacillus anthracis during infection of host macrophages. Infection and Immunity, 75, 3434 - 3444.
13. Bischof, T. S., Hahn, B. L., and Sohnle, P. G. 2007. Characteristics of spore germination in a mouse model of cutaneous anthrax. Journal of Infectious Disease, 195, 888 - 894.
14. Blander, J. M. and Medzhitov, R. 2004. Regulation of phagosome maturation by signals from toll-like receptors. Science, 304, 1014 - 1018.
15. Boyden, E. D. and Dietrich, W. F. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nature Genetics, 38, 240 - 244.
16. Bozue, J., Cote, C. K., Moody, K. L., and Welkos, S. L. 2007a. Fully Virulent Bacillus anthracis does not require the immunodominant protein, BclA, for pathogenesis. Infection and Immunity, 75, 508 - 511.
17. Bozue, J., Moody, K. L., Cote, C. K. et al. 2007b. Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fi broblasts, and endothelial cells but not to macrophages. Infection and Immunity, 75, 4498 - 4505.
18. Bozue, J. A., Parthasarathy, N., Phillips, L. R. et al. 2005. Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs. Microbial Pathogenesis, 38, 1 - 12.
19. Brahmbhatt, T. N., Janes, B. K., Stibitz, E. S. et al. 2007. Bacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicity. Infection and Immunity, 75, 5233 - 5239.
20. Brittingham, K. C., Ruthel, G., Panchal et al. 2005. Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. Journal of Immunology, 174, 5545 - 5552.
21. Buchner, H., Merkel, F., and Enderlen, E. 1888. Archives of Hygiene. Berlin.
22. Budzik, J. M., Oh, S. Y., and Schneewind, O. 2008. Cell Wall Anchor Structure of BcpA Pili in Bacillus anthracis. Journal of Biological Chemistry, 283, 36676 - 36686.
23. Cendrowski, S., MacArthur, W., and Hanna, P. 2004. Bacillus anthracis requires siderophore biosynthesis for growth in macrophages and mouse virulence. Molecular Microbiology, 51, 407 - 417.
24. Chakrabarty, K., Wu, W., Booth, J. L. et al. 2006. Bacillus anthracis spores stimulate cytokine and chemokine innate immune responses in human alveolar macrophages through multiple mitogen-activated protein kinase pathways. Infection and Immunity, 74, 4430 - 4438.
25. Chakrabarty, K., Wu, W., Booth, J. L. et al. 2007. Human lung innate immune response to Bacillus anthracis spore infection. Infection and Immunity, 75, 3729 - 3738.
26. Chandra, H., Gupta, P. K., Sharma, K. et al. 2005. Proteome analysis of mouse macrophages treated with anthrax lethal toxin. Biochimica et Biophysica Acta, 1747, 151 - 159.
27. Chung, M. C., Popova, T. G., Millis, B. A. et al. 2006. Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors. Journal of Biological Chemistry, 281, 31408 - 31418.
28. Cleret, A., Quesnel-Hellmann, A., Mathieu, J. et al. 2006. Resident CD11c + lung cells are impaired by anthrax toxins after spore infection. Journal of Infectious Disease, 194, 86 - 94.
29. Cleret, A., Quesnel-Hellmann, A., Vallon-Eberhard, A. et al. 2007. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. Journal of Immunology, 178, 7994 - 8001.
30. Cocklin, S., Jost, M., Robertson, N. M. et al. 2006. Real-time monitoring of the membrane-binding and insertion properties of the cholesterol-dependent cytolysin anthrolysin O from Bacillus anthracis. Journal of Molecular Recognition, 19, 354 - 362.
31. Cote, C. K., Rea, K. M., Norris, S. L. et al. 2004. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microbial Pathogogenesis, 37, 169 - 175.
32. Cote, C. K., Rossi, C. A., Kang, A. S. et al. 2005. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microbial Pathogenesis, 38, 209 - 225.
33. Cote, C. K., van Rooijen, N. and Welkos, S. L. 2006. The roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores using a mouse model of infection. Infection and Immunity, 74, 469 - 480.
34. Cote, C. K., Bozue, J., Moody, K. L. et al. 2008a. Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization. Microbiology, 154, 619 - 632.
35. Cote, C. K., Dimezzo, T. L., Banks, D. J. et al. 2008b. Early interactions between fully virulent Bacillus anthracis and macrophages that infl uence the balance between spore clearance and development of a lethal infection. Microbes and Infection, 10, 613 - 619.
36. Cowan, G. J., Atkins, H. S., Johnson, L. K. et al. 2007. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis. Vaccine, 25, 7197 - 7205.
37. Cui, X., Moayeri, M., Li, Y. et al. 2004. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not infl ammatory cytokine or nitric oxide release in rats. The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 286, R699 - R709.
38. Cybulski, R. J., Jr., Sanz, P., Alem, F. et al. 2008a. Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress. Infection and Immunity, 77, 274 - 285.
39. Cybulski, R. J., Jr., Sanz, P., McDaniel, D. et al. 2008b. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen. Vaccine, 26, 4927 - 4939.
40. Dawson, R. M. and Liu, C. Q. 2008. Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Critical Reviews in Microbiology, 34, 89 - 107.
41. Dixon, T. C., Fadl, A. A., Koehler, T. M. et al. 2000. Early Bacillus anthracis-macrophage interactions: intracellular survival and escape. Cellular Microbiology, 2, 453 - 463.
42. Drevets, D. A., Canono, B. P., Leenen, P. J., and Campbell, P. A. 1994. Gentamicin kills intracellular Listeria monocytogenes. Infection and Immunity, 62, 2222 - 2228.
43. Drysdale, M., Heninger, S., Hutt, J. et al. 2005. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. The Embo Journal, 24, 221 - 227.
44. Duesbery, N. S., Webb, C. P., Leppla, S. H. et al. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science, 280, 734 - 737.
45. Enkhtuya, J., Kawamoto, K., Kobayashi, Y. et al. 2006. Signifi cant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids. Microbiology, 152, 3103 - 3110.
46. Erwin, J. L., DaSilva, L. M., Bavari, S. et al. 2001. Macrophage-derived cell lines do not express proinfl ammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infection and Immunity, 69, 1175 - 1177.
47. Fischer, S. F., Vier, J., Muller-Thomas, C., and Hacker, G. 2006. Induction of apoptosis by Legionella pneumophila in mammalian cells requires the mitochondrial pathway for caspase activation. Microbes and Infection, 8, 662 - 669.
48. Fisher, N., Shetron-Rama, L., Herring-Palmer, A. et al. 2006. The dltABCD operon of Bacillus anthracis sterne is required for virulence and resistance to peptide, enzymatic, and cellular mediators of innate immunity. Journal of Bacteriology, 188, 1301 - 1309.
49. Fowler, K., McBride, B. W., Turnbull, P. C., and Baillie, L. W. 1999. Immune correlates of protection against anthrax. Journal of Applied Microbiology, 87, 305.
50. Friedlander, A. M. 1986. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. Journal of Biological Chemistry, 261, 7123 - 7126.
51. Friedlander, A. M., Bhatnagar, R., Leppla, S. H. et al. 1993a. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infection and Immunity, 61, 245 - 252.
52. Friedlander, A. M., Welkos, S. L., Pitt, M. L. et al. 1993b. Postexposure prophylaxis against experimental inhalation anthrax. Journal of Infectious Diseases, 167, 1239 - 1243.
53. Friedlander, A. M., Pittman, P. R., and Parker, G. W. 1999. Anthrax vaccine: evidence for safety and effi cacy against inhalational anthrax. The Journal of the American Medical Association, 282, 2104 - 2106.
54. Friedlander, A. M., Welkos, S. L., and Ivins, B. E. 2002. Anthrax vaccines. Current Topics in Microbiology and Immunology, 271, 33 - 60.
55. Ganz, T. and Lehrer, R. I. 1995. Defensins. Pharmacology and Therapeutics, 66, 191 - 205.
56. Gaspar, A. H., Marraffi ni, L. A., Glass, E. M. et al. 2005. Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelope. Journal of Bacteriology, 187, 4646 - 4655.
57. Gat, O., Zaide, G., Inbar, I. et al. 2008. Characterization of Bacillus anthracis iron-regulated surface determinant (Isd) proteins containing NEAT domains. Molecular Microbiology, 70, 983 - 999.
58. Geiser, C. A. 1967. Pathology of anthrax infection in animal hosts. Federal Proceedings, 26, 1518 - 1522.
59. Geiser, C. A., Berdjis, C. C., Hartman, H.A., and Gochenour, W. S. 1963. Pathology of experimental respiratory anthrax in Macaca mulatta. British Journal of Experimental Pathology, 44, 416 - 422.
60. Gimenez, A. P., Wu, Y. Z., Paya, M. et al. 2004. High bactericidal effi ciency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin. Journal of Immunology, 173, 521 - 530.
61. Giorno, R., Bozue, J., Cote, C. et al. 2007. Morphogenesis of the Bacillus anthracis spore. Journal of Bacteriology, 189, 691 - 705.
62. Giorno, R., Mallozzi, M., Bozue, J. et al. 2009. Localization and assembly of proteins comprising the outer structures of the Bacillus anthracis spore. Microbiology, 155 (Pt. 4), 1133 - 1145.
63. Glomski, I. J., Corre, J. P., Mock, M., and Goossens, P. L. 2007a. Noncapsulated toxinogenic Bacillus anthracis presents a specifi c growth and dissemination pattern in naive and protective antigen-immune mice. Infection and Immunity, 75, 4754 - 4761.
64. Glomski, I. J., Piris-Gimenez, A., Huerre et al. 2007. Primary involvement of pharynx and peyer ' s patch in inhalational and intestinal anthrax. PLoS Pathogens, 3, 699 - 708.
65. Glomski, I. J., Dumetz, F., Jouvion, G. et al. 2008. Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specifi c organ targeting. Microbes and Infection, 10, 1398 - 13404.
66. Gold, J. A., Hoshino, Y., Hoshino et al. 2004. Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis. Infection and Immunity, 72, 1291 - 1297.
67. Grinberg, L. M., Abramova, F. A., Yampolskaya, O. V. et al. 2001. Quantitative pathology of inhalational anthrax I: quantitative microscopic fi ndings. Modern Pathology, 14, 482 - 495.
68. Guidi-Rontani, C. 2002. The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends in Microbiology, 10, 405 - 409.
69. Guidi-Rontani, C. and Mock, M. 2002. Macrophage interactions. Current Topics in Microbiology and Immunology, 271, 115 - 141.
70. Guidi-Rontani, C., Pereira, Y., Ruffie et al. 1999a. Identifi cation and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis. Molecular Microbiology, 33, 407 - 414.
71. Guidi-Rontani, C., Weber-Levy, M., Labruyere, E., and Mock, M. 1999b. Germination of Bacillus anthracis spores within alveolar macrophages. Molecular Microbiology, 31, 9 - 17.
72. Guidi-Rontani, C., Levy, M., Ohayon, H., and Mock, M. 2001. Fate of germinated Bacillus anthracis spores in primary murine macrophages. Molecular Microbiology, 42, 931 - 938.
73. Hahn, B. L., Sharma, S., and Sohnle, P. G. 2005. Analysis of epidermal entry in experimental cutaneous Bacillus anthracis infections in mice. Journal of Laboratory and Clinical Medicine, 146, 95 - 102.
74. Hamrick, T. S., Diaz, A. H., Havell, E. A. et al. 2003. Infl uence of extracellular bactericidal agents on bacteria within macrophages. Infection and Immunity, 71, 1016 - 1019.
75. Hanna, P. C. and Ireland, J. A. 1999. Understanding Bacillus anthracis pathogenesis. Trends in Microbiology, 7, 180 - 182.
76. Hanna, P. C., Acosta, D., and Collier, R. J. 1993. On the role of macrophages in anthrax. Proceedings of the National Academy of Science U S A, 90, 10198 - 10201.
77. Heffernan, B. J., Thomason, B., Herring-Palmer, A. et al. 2006. Bacillus anthracis phospholipases C facilitate macrophage-associated growth and contribute to virulence in a murine model of inhalation anthrax. Infection and Immunity, 74, 3756 - 3764.
78. Heine, H. S., Bassett, J., Miller, L. et al. 2007. Determination of antibiotic effi cacy against Bacillus anthracis in a mouse aerosol challenge model. Antimicrobial Agents and Chemotherapy, 51, 1373 - 1379.
79. Henderson, D. W., Peacock, S., and Belton, F. C. 1956. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. The Journal of Hygiene (London), 54, 28 - 36.
80. Heninger, S., Drysdale, M., Lovchik, J. et al. 2006. Toxin-defi cient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Infection and Immunity, 74, 6067 - 6074.
81. Hering, D., Thompson, W., Hewetson, J. et al. 2004. Validation of the anthrax lethal toxin neutralization assay. Biologicals, 32, 17 - 27.
82. Hoover, D. L., Friedlander, A. M., Rogers, L. C. et al. 1994. Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infection and Immunity, 62, 4432 - 4439.
83. Hu, H., Sa, Q., Koehler, T. M. et al. 2006. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cellular Microbiology, 8, 1634 - 1642.
84. Hu, H., Emerson, J., and Aronson, A. I. 2007. Factors involved in the germination and inactivation of Bacillus anthracis spores in murine primary macrophages. FEMS Microbiology Letters, 272, 245 - 250.
85. Ireland, J. and Hanna, P. C. 2002. Macrophage-enhanced germination of Bacillus anthracis endospores requires gerS. Infection and Immunity, 70, 5870 - 5872.
86. Ivins, B. E., Ezzell, J. W., Jr., Jemski, J. et al. 1986. Immunization studies with attenuated strains of Bacillus anthracis. Infection and Immunity, 52, 454 - 458.
87. Ivins, B. E., Fellows, P. F., and Nelson, G. O. 1994. Effi cacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea pigs. Vaccine, 12, 872 - 874.
88. Kalns, J., Scruggs, J., Millenbaugh, N. et al. 2002. TNF receptor 1, IL-1 receptor, and iNOS genetic knockout mice are not protected from anthrax infection. Biochemical and Biophysical Research Communications, 292, 41 - 44.
89. Kang, T. J., Fenton, M. J., Weiner, M. A. et al. 2005. Murine macrophages kill the vegetative form of Bacillus anthracis. Infection and Immunity, 73, 7495 - 7501.
90. Kang, T. J., Basu, S., Zhang, L. et al. 2008. Bacillus anthracis spores and lethal toxin induce IL-1beta via functionally distinct signaling pathways. European Journal of Immunology, 38, 1574 - 1584.
91. Kassam, A., Der, S. D., and Mogridge, J. 2005. Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin. Cellular Microbiology, 7, 281 - 292.
92. Keppie, J., Smith, H., and Harris-Smith, P. W. 1953. The chemical basis of the virulence of Bacillus anthracis. II. Some biological properties of bacterial products. British Journal of Experimental Pathology, 34, 486 - 496.
93. Keppie, J., Harris-Smith, P. W., and Smith, H. 1963. The Chemical Basis of the Virulence of Bacillus Anthracis. IX. Its aggressins and their mode of action. British Journal of Experimental Pathology, 44, 446 - 453.
94. Kim, C., Gajendran, N., Mittrucker, H. W. et al. 2005. Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proceedings of the National Academy of Science U S A, 102, 4830 - 4835.
95. Kobiler, D., Gozes, Y., Rosenberg, H. et al. 2002. Effi ciency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infection and Immunity, 70, 544 - 560.
96. Koduri, R. S., Gronroos, J. O., Laine, V. J. et al. 2002. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). Journal of Biological Chemistry, 277, 5849 - 5857.
97. Kuhn, J. F., Hoerth, P., Hoehn, S. T. et al. 2006. Proteomics study of anthrax lethal toxin-treated murine macrophages. Electrophoresis, 27, 1584 - 1597.
98. Lehrer, R. I. 2004. Primate defensins. Nature Reviews, Microbiology, 2, 727 - 738.
99. Lincoln, R. E., Walker, J. S., Klein, F. et al. 1967. Value of fi eld data for extrapolation in anthrax. Federal Proceedings, 26, 1558 - 1562.
100. Little, S. F. and Knudson, G. B. 1986. Comparative effi cacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infection and Immunity, 52, 509 - 512.
101. Little, S. F., Ivins, B. E., Fellows, P. F. et al. 2004a. Defi ning a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine, 22, 422 - 430.
102. Little, S. F., Webster, W. M., Norris, S. L., and Andrews, G. P. 2004b. Evaluation of an anti-rPA IgG ELISA for measuring the antibody response in mice. Biologicals, 32, 62 - 69.
103. Little, S. F., Ivins, B. E., Webster, W. M. et al. 2007. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine. Vaccine, 25, 2771 - 2777.
104. Loving, C. L., Kennett, M., Lee, G. M. et al. 2007. Murine aerosol challenge model of anthrax. Infection and Immunity, 75, 2689 - 2698.
105. Mack, J., Vermeiren, C., Heinrichs, D. E., and Stillman, M. J. 2004. In vivo heme scavenging by Staphylococcus aureus IsdC and IsdE proteins. Biochemical and Biophysical Research Communications, 320, 781 - 788.
106. Madle-Samardzija, N., Turkulov, V., Vukadinov, J. et al. 2002. Anthrax - the past, present and future. Medicnski Pregled, 55, 114 - 119.
107. Makino, S., Uchida, I., Terakado, N. et al. 1989. Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. Journal of Bacteriology, 171, 722 - 730.
108. Mallozzi, M., Bozue, J., Giorno, R. et al. 2008. Characterization of a Bacillus anthracis spore coat-surface protein that infl uences coat-surface morphology. FEMS Microbiology Letters, 289, 110 - 117.
109. Marcus, H., Danieli, R., Epstein, E. et al. 2004. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine. Infection and Immunity, 72, 3471 - 3477.
110. Maresso, A. W., Chapa, T. J., and Schneewind, O. 2006. Surface protein IsdC and Sortase B are required for heme-iron scavenging of Bacillus anthracis. Journal of Bacteriology, 188, 8145 - 8152.
111. Marraffi ni, L. A., Dedent, A. C., and Schneewind, O. 2006. Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiology and Molecular Biology Reviews, 70, 192 - 221.
112. Martinon, F. 2007. Orchestration of pathogen recognition by infl ammasome diversity: Variations on a common theme. European Journal of Immunology, 37, 3003 - 3006.
113. Mayer-Scholl, A., Hurwitz, R., Brinkmann, V. et al. 2005. Human neutrophils kill Bacillus anthracis. PLoS, Pathogens, 1, 179 - 186.
114. Metchnikoff, E. 1905. Immunity to infective diseases Cambridge: Cambridge University Press. Moayeri, M. and Leppla, S. H. 2004. The roles of anthrax toxin in pathogenesis. Current Opinion in Microbiology, 7, 19 - 24.
115. Moayeri, M., Haines, D., Young, H. A., and Leppla, S. H. 2003. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. The Journal of Clinical Investigation, 112, 670 - 682.
116. Moayeri, M., Martinez, N. W., Wiggins, J. et al. 2004. Mouse susceptibility to anthrax lethal toxin is infl uenced by genetic factors in addition to those controlling macrophage sensitivity. Infection and Immunity, 72, 4439 - 4447.
117. Moody, K., Driks, A., Rother, G., Cote, C., Brueggemann, E., Hines, H., Friedlander, A., and Bozue, J. 2010. Processing, assembly and localization of a Bacillus anthracis spore protein. Microbiology, 156, 174 - 183.
118. Mosser, E. M. and Rest, R. F. 2006. The Bacillus anthracis cholesterol-dependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages. BMC Microbiology, 6, 56.
119. Newton, S. M., Klebba, P. E., Raynaud, C. et al. 2005. The svpA-srtB locus of Listeria monocytogenes: fur-mediated iron regulation and effect on virulence. Molecular Microbiology, 55, 927 - 940.
120. Oliva, C. R., Swiecki, M. K., Griguer, C. E. et al. 2008. The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proceedings of the National Academy of Science, U S A, 105, 1261 - 1266.
121. Park, J. M., Greten, F. R., Li, Z. W., and Karin, M. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science, 297, 2048 - 2051.
122. Park, J. M., Ng, V. H., Maeda, S. et al. 2004. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. Journal of Experimental Medicine, 200, 1647 - 1655.
123. Park, J. M., Greten, F. R., Wong, A. et al. 2005. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis - CREB and NF-kappaB as key regulators. Immunity, 23, 319 - 329.
124. Passalacqua, K. D. and Bergman, N. H. 2006. Bacillus anthracis: interactions with the host and establishment of inhalational anthrax. Future Microbiology, 1, 397 - 415.
125. Patterson-Delafi eld, J., Martinez, R. J., and Lehrer, R. I. 1980. Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infection and Immunity, 30, 180 - 192.
126. Peachman, K. K., Rao, M., Alving, C. R. et al. 2006. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Infection and Immunity, 74, 794 - 797.
127. Pellizzari, R., Guidi-Rontani, C., Vitale, G. et al. 1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Letters, 462, 199 - 204.
128. Pellizzari, R., Guidi-Rontani, C., Vitale, C. et al. 2000. Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages. International Journal of Medical Microbiology, 290, 421 - 427.
129. Peterson, J. W., Comer, J. E., Baze, W. B. et al. 2007. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Infection and Immunity, 75, 3414 - 3424.
130. Phipps, A. J., Premanandan, C., Barnewall, R. E., and Lairmore, M. D. 2004. Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines. Microbiology and Molecular Biology Reviews, 68, 617 - 629.
131. Pickering, A. K. and Merkel, T. J. 2004. Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores. Infection and Immunity, 72, 3069 - 3072.
132. Pickering, A. K., Osorio, M., Lee, G. M. et al. 2004. Cytokine response to infection with Bacillus anthracis spores. Infection and Immunity, 72, 6382 - 6389.
133. Piris-Gimenez, A., Wu, Y.-Z., Paya, M. et al. 2004. High bactericidal effi ciency of type IIA phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin. Journal of Immunology, 173, 521 - 530.
134. Piris-Gimenez, A., Paya, M., Lambeau, G. et al. 2005. In vivo protective role of human group IIa phospholipase A2 against experimental anthrax. Journal of Immunology, 175, 6786 - 6791.
135. Pitt, M. L., Little, S. F., Ivins, B. E. et al. 2001. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine, 19, 4768 - 4773.
136. Pittman, P. R., Kim-Ahn, G., Pifat, D. Y. et al. 2002. Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine, 20, 1412 - 1420.
137. Popov, S. G., Villasmil, R., Bernardi, J. et al. 2002a. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochemical and Biophysical Research Communications, 293, 349 - 355.
138. Popov, S. G., Villasmil, R., Bernardi, J. et al. 2002b. Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Letters, 527, 211 - 215.
139. Popov, S. G., Popova, T. G., Grene, E. et al. 2004. Systemic cytokine response in murine anthrax. Cellular Microbiology, 6, 225 - 233.
140. Raines, K. W., Kang, T. J., Hibbs, S. et al. 2006. Importance of nitric oxide synthase in the control of infection by Bacillus anthracis. Infection and Immunity, 74, 2268 - 2276.
141. Raymond, B., Leduc, D., Ravaux, L. et al. 2007. Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages. PLoS Pathogens, 3, 1907 - 1917.
142. Read, T. D., Peterson, S. N., Tourasse, N. et al. 2003. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature, 423, 81 - 86.
143. Reig, N., Jiang, A., Couture, R. et al. 2008. Maturation modulates caspase-1-independent responses of dendritic cells to Anthrax lethal toxin. Cellular Microbiology, 10, 1190 - 1207.
144. Reuveny, S., White, M. D., Adar, Y. Y. et al. 2001. Search for correlates of protective immunity conferred by anthrax vaccine. Infection and Immunity, 69, 2888 - 2893.
145. Ribot, W. J., Panchal, R. G., Brittingham, K. C. et al. 2006. Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival. Infection and Immunity, 74, 5029 - 5034.
146. Roberts, J. E., Watters, J. W., Ballard, J. D., and Dietrich, W. F. 1998. Ltx1, a mouse locus that infl uences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11. Molecular Microbiology, 29, 581 - 591.
147. Ross, J. M. 1957. The Pathogenesis of Anthrax Following the Administration of Spores by the Respiratory Route. Journal of Pathology and Bacteriology, 73, 485 - 494.
148. Russell, B. H., Vasan, R., Keene, D. R., and Xu, Y. 2007. Bacillus anthracis internalization by human fi broblasts and epithelial cells. Cellular Microbiology, 9, 1262 - 1274.
149. Russell, B. H., Liu, Q., Jenkins, S. A. et al. 2008a. In vivo demonstration and quantifi cation of intracellular Bacillus anthracis in lung epithelial cells. Infection and Immunity, 76, 3975 - 3983.
150. Russell, B. H., Vasan, R., Keene, D. R. et al. 2008b. Potential dissemination of Bacillus anthracis utilizing human lung epithelial cells. Cellular Microbiology, 10, 945 - 957.
151. Ruthel, G., Ribot, W. J., Bavari, S., and Hoover, T. A. 2004. Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. Journal of Infectious Diseases, 189, 1313 - 1316.
152. Ryan, L. K., Rhodes, J., Bhat, M., and Diamond, G. 1998. Expression of beta-defensin genes in bovine alveolar macrophages. Infection and Immunity, 66, 878 - 881.
153. Sabet, M., Cottam, H. B., and Guiney, D. G. 2006. Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages. FEMS Immunology and Medical Microbiology, 47, 369 - 379.
154. Sanz, P., Teel, L. D., Alem, F. et al. 2008. Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging. Infection and Immunity, 76, 1036 - 1047.
155. Sapra, R., Gaucher, S. P., Lachmann, J. S. et al. 2006. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin. Microbial Pathogenesis, 41, 157 - 167.
156. Sawada-Hirai, R., Jiang, I., Wang, F. et al. 2004. Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed. Journal of Immune Based Therapies and Vaccines, 2, 5.
157. Scorpio, A., Chabot, D. J., Day, W. A. et al. 2007. Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis. Antimicrobial Agents and Chemotherapy, 51, 215 - 222.
158. Scorpio, A., Tobery, S. A., Ribot, W. J., and Friedlander, A. M. 2008. Treatment of experimental anthrax with recombinant capsule depolymerase. Antimicrobial Agents and Chemotherapy, 52, 1014 - 1020.
159. Seo, G. M., Jung, K. H., Kim, S. J. et al. 2008. Bacillus anthracis spores infl uence ATP synthase activity in murine macrophages. Journal of Microbiology and Biotechnology, 18, 778 - 783.
160. Shannon, J. G., Ross, C. L., Koehler, T. M., and Rest, R. F. 2003. Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin. Infection and Immunity, 71, 3183 - 3189.
161. Shatalin, K., Gusarov, I., Avetissova, E. et al. 2008. Bacillus anthracis-derived nitric oxide is essential for pathogen virulence and survival in macrophages. Proceedings of the National Academy of Science, U S A, 105, 1009 - 1013.
162. Singh, Y., Leppla, S. H., Bhatnagar, R., and Friedlander, A. M. 1989. Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and-resistant cells. Journal of Biological Chemistry, 264, 11099 - 11102.
163. Skaar, E. P., Gaspar, A. H., and Schneewind, O. 2006. Bacillus anthracis IsdG, a heme-degrading monooxygenase. Journal of Bacteriology, 188, 1071 - 1080.
164. Steichen, C., Chen, P., Kearney, J. F., and Turnbough, C. L., Jr. 2003. Identifi cation of the immunodominant protein and other proteins of the Bacillus anthracis exosporium. Journal of Bacteriology, 185, 1903 - 1910.
165. Stepanov, A. V., Marinin, L. I., Pomerantsev, A. P., and Staritsin, N. A. 1996. Development of novel vaccines against anthrax in man. Journal of Biotechnology, 44, 155 - 160.
166. Sylvestre, P., Couture-Tosi, E., and Mock, M. 2002. A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Molecular Microbiology, 45, 169 - 178.
167. Tang, Y. Q., Yuan, J., Osapay, G. et al. 1999. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science, 286, 498 - 502.
168. Thoma-Uszynski, S., Stenger, S., Takeuchi, O. et al. 2001. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science, 291, 1544 - 1547.
169. Thwaite, J. E., Hibbs, S., Titball, R. W., and Atkins, T. P. 2006. Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrobial Agents and Chemotherapy, 50, 2316 - 2322.
170. Tilney, L. G., Harb, O. S., Connelly, P. S. et al. 2001. How the parasitic bacterium Legionella pneumophila modifi es its phagosome and transforms it into rough ER: implications for conversion of plasma membrane to the ER membrane. Journal of Cell science, 114, 4637 - 4650.
171. Tournier, J. N., Quesnel-Hellmann, A., Mathieu, J. et al. 2005. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. Journal of Immunology, 174, 4934 - 4941.
172. Tournier, J. N., Quesnel-Hellmann, A., Cleret, A. et al. 2006. Anthrax revisited: Bacillus anthracis toxins as novel actors of immune escape? Bulletin de l'Acad é mie nationale de m é decine, 190, 155 - 163.
173. Tournier, J. N., Quesnel-Hellmann, A., Cleret, A., and Vidal, D. R. 2007. Contribution of toxins to the pathogenesis of inhalational anthrax. Cellular Microbiology, 9, 555 - 565.
174. Tournier, J. N., Cleret, A., and Quesnel-Hellmann, A. 2009. What is the relevance of lung epithelial cells during the dissemination of spores in inhalational anthrax? Infection and Immunity, 77, 565 ; author reply 565 - 566.
175. Tschopp, J. 1989. NALPs: Resistance to Sterne strain of Bacillus anthracis: Phagocytic cell response of resistant and susceptible mice. Microbial Pathogenesis, 7, 15 - 35.
176. Turnbull, P. C., Broster, M. G., Carman, J. A. et al. 1986. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infection and Immunity, 52, 356 - 363.
177. Unanue, E. R. and DeGregario, E. 2005. Interactions of pathogens with the innate and adaptive immune systems. In Cellular Microbiology, ed. P. Cossart, P. Boquet, S. Normark and R. Rappuoli, 425 - 449. Washington, DC: ASM Press.
178. Viator, R. J., Rest, R. F., Hildebrandt, E., and McGee, D. J. 2008. Characterization of Bacillus anthracis arginase: effects of pH, temperature, and cell viability on metal preference. BMC Biochemistry, 9, 15.
179. Vietri, N. J., Purcell, B. K., Lawler, J. V. et al. 2006. Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax. Proceedings of the National Academy of Science, U S A, 103, 7813 - 7816.
180. Wang, W., Mulakala, C., Ward, S. C. et al. 2006. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. Journal of Biological Chemistry, 281, 32755 - 32764.
181. Weaver, J., Kang, T. J., Raines, K. W. et al. 2007. Protective role of Bacillus anthracis exosporium in macrophage-mediated killing by nitric oxide. Infection and Immunity, 75, 3894 - 3901.
182. Weiner, M. A. and Hanna, P. C. 2003. Macrophage-mediated germination of Bacillus anthracis endospores requires the gerH operon. Infection and Immunity, 71, 3954 - 3959.
183. Weinrauch, Y., Elsbach, P., Madsen, L. M. et al. 1996. The potent anti-Staphylococcus aureus activity of a sterile rabbit infl ammatory fl uid is due to a 14-kD phospholipase A2. Journal of Clinical Investigation, 97, 250 - 257.
184. Welkos, S., Friedlander, A., Weeks, S. et al. 2002. In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. Journal of Medical Microbiology, 51, 821 - 831.
185. Welkos, S. L., Keener, T. J., and Gibbs, P. H. 1986. Differences in susceptibility of inbred mice to Bacillus anthracis. Infection and Immunity, 51, 795 - 800.
186. Welkos, S. L. and Friedlander, A. M. 1988a. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microbial Pathogenesis, 4, 53 - 69.
187. Welkos, S. L. and Friedlander, A. M. 1988b. Comparative safety and effi cacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microbial Pathogenesis, 5, 127 - 139.
188. Welkos, S. L., Trotter, R. W., Becker, D. M., and Nelson, G. O. 1989. Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microbial Pathogenesis, 7, 15 - 35.
189. Welkos, S., Becker, D., Friedlander, A., and Trotter, R. 1990. Pathogenesis and host resistance to Bacillus anthracis: a mouse model. Salisbury Medical Bulletin, 87, 49 - 52.
190. Welkos, S. L., Cote, C. K., Rea, K. M., and Gibbs, P. H. 2004. A microtiter fl uorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies. Journal of Microbiological Methods, 56, 253 - 265.
191. Willhite, D. C. and Blanke, S. R. 2004. Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cellular Microbiology, 6, 143 - 154.
192. Williamson, E. D., Beedham, R. J., Bennett, A. M. et al. 1999. Presentation of protective antigen to the mouse immune system: immune sequelae. Journal of Applied Microbiology, 87, 315 - 317.
193. Williamson, E. D., Hodgson, I., Walker, N. J. et al. 2005. Immunogenicity of recombinant protective antigen and effi cacy against aerosol challenge with anthrax. Infection and Immunity, 73, 5978 - 5987.
194. Yang, D., Liu, Z. H., Tewary, P. et al. 2007. Defensin participation in innate and adaptive immunity. Current Pharmaceutical Design, 13, 3131 - 3139.
195. Young, G. A., Zelle, M. R., and Lincoln, R. E. 1946. Respiratory pathogenicity of Bacillus anthracis spores. I. Methods of study and observations on pathogenesis. Journal of Infectious Diseases, 79, 233 - 246.
196. Zenewicz, L. A., Wei, Z., Goldfi ne, H., and Shen, H. 2005. Phosphatidylinositol-specifi c phospholipase C of Bacillus anthracis down-modulates the immune response. Journal of Immunology, 174, 8011 - 8016.
197. Zink, S. D. and Burns, D. L. 2005. Importance of srtA and srtB for growth of Bacillus anthracis in macrophages. Infection and Immunity, 73, 5222 - 5228.